Foghorn Therapeutics Financial Overview
Foghorn Therapeutics's market cap is currently $253.35M. The company's EPS TTM is $-0.25; its P/E ratio is -3.91; Foghorn Therapeutics is scheduled to report earnings on November 5, 2025, and the estimated EPS forecast is $-0.26. See an overview of income statement, balance sheet, and cash flow financials.
